3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
11
Ovarian Neoplasms
5
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Radiation Pneumonitis
2
Peritoneal Neoplasms
2
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neuroendocrine Tumors
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Inflammatory Breast Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Esophagogastric Adenocarcinoma
1
Endometrial Adenocarcinoma
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoid Tumor
1
Breast Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Carboplatin
42
Etoposide
37
Cisplatin
23
Topotecan
22
Nivolumab
17
pembrolizumab
12
atezolizumab
12
Ipilimumab
10
Paclitaxel
9
durvalumab
8
Irinotecan
8
Radiosurgery
6
Pemetrexed
6
rovalpituzumab tesirine
5
Magnetic Resonance Spectroscopy
5
trioctyl phosphine oxide
4
trilaciclib
4
etoposide phosphate
4
berzosertib
4
Sunitinib
4
Specimen Handling
4
Platinum
4
PM 01183
4
Dexamethasone
4
veliparib
3
tremelimumab
3
olaparib
3
carfilzomib
3
cabozantinib
3
Temozolomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Small Cell Lung Carcinoma
×
nintedanib
×
Clear all
No trials found.